New approaches, solutions and outlooks on biologised medical technology developed in the Berlin metropolitan region were presented at this year’s annual 'Medical technology meeting place' in Berlin, which presents the latest research, new product developments and best practice examples from the greater-Berlin area. report: Bettina Döbereiner
The ‘Fire of Life’ developed by Schiller is an intuitive visual presentation of frequency-domain heart rate variability (HRV) that makes the assessment of 24-hour results fast and simple.
‘There are aspects of the heart’s physiology that we know about, but now we can see them, and this is absolutely different,’ said Patrizio Lancellotti, President of the European Association of Cardiovascular Imaging.
Evidence is scant on the cooling of comatose patients who have suffered cardiac arrest, stroke or traumatic brain injuries; nevertheless, new methods for cooling patients are continuously being developed.
Radiotherapy is being proposed to treat heart diseases, specifically for hypertension and atrial fibrillation (AF).
The significant benefits of cardiac catherisation remain undisputed. However, cross-sectional imaging modalities are serious competitors when it comes to arriving at the right diagnosis.
No need to ask who was really shocked by the Halle Shock trial, followed by the multi-centre Shock II trial.
Whether mechanical, temporary cardiac assist systems should pulsate in the same way as a biological heart is a discussion topic, which raises the pulse rates amongst all those involved within the industry and in hospitals.
The significant benefits of cardiac catherisation remain undisputed. However, cross-sectional imaging modalities are serious competitors when it comes to arriving at the right diagnosis.
The heart is a structure in three dimensions and today we see it in three dimensions,’ Jose Luis Zamorano Gomez MD declared with satisfaction.
A cardiac surgeon, Wolfgang Goetz MD once stitched together custom aortic valves in the operating room. Today he is CEO of Transcatheter Technologies in Regensburg.
French authorities have given the green light for continuing the clinical trial for the first fully implantable mechanical heart after a four-month review of the device and the causes of death of the first patient to receive the prosthesis
This summer the world’s first implantations of Biotronik’s new ICD and CRT-D series (implantable cardioverter-defibrillators and cardiac resynchronisation therapy defibrillators) took place at the Spedali Civili Hospital, Brescia, Italy.
A session at the forthcoming British Cardiovascular Society annual conference (2-4 June, in Manchester) will hear about the latest imaging techniques for acquired heart disease, with PET technology playing a key role in those advances.
As well as this year’s programme being the biggest yet, with 76 plenary sessions, there are also sponsored symposia from Janssen and CamNutra. Additionally, the USA’s Mayo Clinic will provide the Cardiology Review Course, with representatives from Rochester, Minnesota, delivering some sessions.
A hybrid operating theatre is considered ideal for TAVI because cardiologists and cardiac surgeons can work hand in hand. Here, in the hybrid theatre at Kerckhoff Heart Centre, Bad Nauheim, a transcatheter aortic valve implant with transfemoral access is being performed. The clean air room features cardiac cath lab equipment and an X-ray system.
Biotronik, a leading manufacturer of cardiovascular medical technology, announced CE approval for its new Eluna pacemaker series. The new generation of pacemakers includes single and dual-chamber as well as cardiac resynchronization (CRT-P) devices.
In a study that began in a pair of infant siblings with a rare heart defect, Johns Hopkins researchers say they have identified a key molecular switch that regulates heart cell division and normally turns the process off around the time of birth. Their research, they report, could advance efforts to turn the process back on and regenerate heart tissue damaged by heart attacks or disease.
Fully implantable mechanical hearts bring hope to 121,000 heart failure patients who will never receive a heart transplant
With low tube voltage, reduced radiation and contrast agent dose, the system delivers sufficient and meaningful data
Poor growth in the first three months of pregnancy is associated with a range of cardiovascular risk factors in childhood, finds a study published on bmj.com.
Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis
The Plaque-CharM project funded by the German Federal Ministry of Education and Research is to develop novel sensor technology that can characterise arterial tissue in the smallest space – the tip of a catheter.
Prevention Suite’s four combined imaging technologies enables practical pre-clinical assessment of cardiovascular disease risk .
Okan Ekinci, Global Director of Cardiology at Siemens Healthcare, is convinced that, ultimately, ultrasound will remain the ‘entry level’ imaging procedure for patients. European Hospital met up with him at this year’s ESC congress to hear his thoughts on the potential of ultrasound – and particularly its fusion with other imaging modalities.
